5.92

8.64% -0.56

After Hours: 6.25 0.33 +5.57%

Hyperion Defi Inc (HYPD)

Overview News Price History Discussions Forecast

Hyperion Defi Inc stock is traded at $5.92, with a volume of 633.04K. It is down -8.64% in the last 24 hours and down -46.52% over the past month. Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or New combinations.

Previous Close:

$6.48

Open:

$6.33

24h Volume:

633.04K

Relative Volume:

0.84

Market Cap:

$33.71M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-29.10%

1M Performance:

-46.52%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$5.76

$6.46

1-Week Range:

$5.76

$9.13

52-Week Range:

$5.075

$16.12

Hyperion Defi Inc Stock (HYPD) Company Profile

Name

Hyperion Defi Inc

Sector

Healthcare (1136)

Industry

Biotechnology (633)

Phone

813-766-9539

Address

295 MADISON AVENUE,, NEW YORK

Employee

Twitter

Next Earnings Date

Latest SEC Filings

HYPD's Discussions on Twitter

Compare HYPD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYPD Hyperion Defi Inc	5.92	63.96M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-24	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-01-21	Initiated	Northland Capital	Outperform
Feb-03-20	Downgrade	Oppenheimer	Outperform → Perform

Hyperion Defi Inc Stock (HYPD) Latest News

Nov 03, 2025

Hyperion DeFi Schedules Third Quarter 2025 Earnings Call for November 13, 2025 - The Manila Times

Nov 03, 2025

Hyperion DeFi (NASDAQ: HYPD) schedules third quarter 2025 earnings call at 5 p.m. ET - Stock Titan

Nov 03, 2025

Hyperion DeFi announces strategic partnership with Felix to launch HIP-3 powered perpetual futures market - MarketScreener

Oct 29, 2025

Hyperion DeFi (HYPD) and Felix Forge Strategic Alliance in DeFi Landscape - GuruFocus

Oct 29, 2025

Hyperion DeFi Announces Strategic Partnership with Felix to Launch HIP-3 Powered Perpetual Futures Market - The Globe and Mail

Oct 29, 2025

Hyperion DeFi (NASDAQ: HYPD) to provide 500K HYPE for Felix HIP-3 perpetual futures market - Stock Titan

Oct 29, 2025

Hyperion DeFi, Inc. (NASDAQ:HYPD) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat

Oct 29, 2025

Oct 26, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Hyperion DeFi (NASDAQ:HYPD) - MarketBeat

Oct 26, 2025

Oct 18, 2025

David R. Knox Net Worth (2025) - GuruFocus

Oct 18, 2025

Oct 16, 2025

Hyperion DeFi, Inc.Common Stock (NQ: HYPD - FinancialContent

Oct 16, 2025

Oct 15, 2025